Volume 45, Issue 4 pp. 773-782
Experimental Cancer
Full Access

Identification of T-cell antigens expressed by metastatic T-cell hybridomas and lymphomas

Dominique Van Hecke

Corresponding Author

Dominique Van Hecke

Institute for Molecular Biology, Free University of Brussels, Paardenstraat 65, 1640 Sint-Genesius-Rode, Belgium

Institute for Molecular Biology, Free University of Brussels, Paardenstraat 65, 1640 Sint-Genesius-Rode, BelgiumSearch for more papers by this author
Hendrik Verschueren

Hendrik Verschueren

Pasteur Institute Brabant, B-1180 Brussels, Belgium

Search for more papers by this author
Patrick De Baetselier

Patrick De Baetselier

Institute for Molecular Biology, Free University of Brussels, Paardenstraat 65, 1640 Sint-Genesius-Rode, Belgium

Search for more papers by this author
First published: 15 April 1990
Citations: 7

Abstract

Using the murine BW5147 tumor model system, we have identified 3 MAbs that discriminate between metastatic and non-metastatic BW5147-derived T-cell hybridomas and BW5147-unrelated T-lymphomas. The 3 rat MAbs appear to recognize an identical membrane-associated sialoglycoprotein with an approximate molecular weight of 95–100 kDa. We thus defined “metastatic T-cell hybridoma” antigens (MTH-Ags) that are also expressed on normal T-lymphocytes. No correlation was found between the expression of the MTH Ags and in vitro invasive behavior of normal and malignant cells. Neither did we find any relationship between organ specificity of i.v. inoculated tumor cells and their MTH-Ags expression. It thus remains unclear whether our MTH-Ags are functionally involved in the metastatic process, or whether their expression is only incidentally related to the metastatic potential.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.